Genesis Biosystems – DermaFrac C – Micro-Protrusion + Infusion
SKU: GBDFC2
Genesis Biosystems – DermaFrac C® – Micro-Protrusion + Infusion
Print Order Form – click here for On-Line Order Form:
System Includes: Derma Frac® C Console, Power Cord, Power Supply, DermaFrac® Handpiece, Tubing Set, Waste Canister and Customer’s Choice of 20 assorted Single Procedure Kits listed on order form and 1 pack of brochures. (Carry Bag available as separate purchase.)
Derma Frac® C
The Derma Frac® C is a dual-modality platform, that offers non-invasive micro-exfoliation treatment that debrides the skin, while simultaneously applying topical serums to address specific goals for skin conditioning.
Compact and Powerful
-
Two modalities
-
Simple-to-use interface design
-
2 handpieces for customizable procedure options
-
Disposable exfoliation and micro-protrusion tips, and cartridges
-
No anesthetic required
-
No downtime
More infusion means more results
- Pain Free, no topical anesthetic
- Facilitates micro-protrusion with simultaneous topical infusion
- Improved appearance of the skin
- Faster, more treatments per day
- Safer, more predictable
- Greater profits
Deliver rejuvenating topical solutions with no pain or downtime for improved texture and luminosity of the skin.
DermaFrac® C is ideal for:
1. Smaller treatment spaces
2. Travel between multiple rooms or locations
3. Aestheticians, spas, home-based offices, sole proprietors
2. Travel between multiple rooms or locations
3. Aestheticians, spas, home-based offices, sole proprietors
DermaFrac® C eliminates:
1. extra steps of delivering topicals separately into the skin
2. the need for anesthesia
3. risk for darker skin types
4. complications and expense of laser treatments & heat issues
2. the need for anesthesia
3. risk for darker skin types
4. complications and expense of laser treatments & heat issues
REQUEST MORE INFORMATION
80+ name brands to choose from
Serving over 7,500 Med Spas nationwide
Helping Med Spas Stock Smarter – One Click at a Time
Reviews
There are no reviews yet.